Clinical trial
Collision of Three Global Pandemics: the Effect of Tuberculosis and HIV on the Epidemiological, Clinical, Virological and Immunological Trajectory of COVID-19 in Botswana and Namibia
NCT05268380 is registered in ClinicalTrials.gov with University of Namibia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Collision of Three Global Pandemics: the Effect of Tuberculosis and HIV on the Epidemiological, Clinical, Virological and Immunological Trajectory of COVID-19 in Botswana and Namibia
- Lead sponsor
- University of Namibia
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 1, 2022
- Completion date
- February 29, 2024
- Enrollment
- 1,750 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19, hiv seropositivity, tuberculosis infection, tuberculosis, pulmonary